Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of ...

Weight loss injections are now available on the NHS but experts warn thousands of patients may be vulnerable to serious side ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

For people who constantly think about what they are going to eat meal to meal, their food noise goes down significantly’ ...

Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term habits still matter most.

Eli Lilly's Mounjaro diabetes and weight-loss drug approved in India in KwikPen device, offering personalized treatment ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...

While real-time data on how Indians are responding to these drugs is still emerging, experts say that sustained weight loss ...

Rochelle McDonald has just been through the messiest of break-ups. “Guzman y Gomez were devastated,” she says, but 17 kilos ...

Going on holiday with weight-loss jabs could land you in a lot of trouble as they are banned or regulated in some countries ...

Mounjaro has released once-weekly injections that are helpful in managing type 2 diabetes along with showing remarkable ...